Lv2
190 积分 2024-07-15 加入
CD39 and CD73 Expression in Breast Cancer: CD73 as a Favorable Prognostic Factor in HER2-Positive Tumors
13小时前
待确认
Expression and clinical significance of CD155, FGL1, Galectin-9, and PD‑L1 in breast cancer with neoadjuvant chemotherapy
19天前
已完结
Abstract 203: Promotion of metastasis of ERBB2-positive breast cancer by mesenchymal stem cells via exosomes-mediated activation of ERBB2/ERBB3→PI3K/Akt singaling pathway
27天前
已关闭
Global patterns and trends in breast cancer incidence and mortality across 185 countries
1个月前
已完结
Emerging importance of HER3 in tumorigenesis and cancer therapy
1个月前
已完结
Evaluation of PD-L1, tumor-infiltrating lymphocytes, and CD8+ and FOXP3+ immune cells in HER2-positive breast cancer treated with neoadjuvant therapies
1个月前
已关闭
p95HER2, a truncated form of the HER2 oncoprotein, drives an immunosuppressive program in HER2+ breast cancer that limits trastuzumab deruxtecan efficacy
1个月前
已完结
Adipocyte fatty acid binding protein 4 (FABP4) inhibitors. An update from 2017 to early 2022
1个月前
已完结
Clinico-Pathological and Prognostic Significance of a Combination of Tumor Biomarkers in Iranian Patients With Breast Cancer
2个月前
已完结
Pathogenic HER3 dimerization domain mutations create a structural bias towards un-conventional EGFR-HER3 signalling axis in breast cancer
2个月前
已完结
皖公网安备34019202002308
